Homepage
Wersja polska
Our offer
Science
News & events
Careers
About us
Investor relations
Contact
Drug discovery
Therapeutic area expertise
Oncology
Central Nervous System
Autoimmune disorders
Infectious disorders
Medicinal chemistry
Virtual screening
In silico compound profiling
Target-focused library design
Lead optimization
Target identification and modeling
Chemical development services
Analytical chemistry services
Custom synthesis
Drug form development support
Biology services
Protein kinase studies
Pharmacodynamics
ADME
DMPK studies
Toxicity studies
Molecular cell biology for drug discovery
Biochemistry services
Comparative studies of biosimilar medicinal products
Innovative compounds
Current pipeline
IT for research
Selvita is a product and solution provider
for the pharmaceutical and biotechnology industry. We deliver comprehensive solutions to the customers from pharma & biotech industry targeted at lowering the cost of introducing innovative therapeutical compounds to the market...
News
Selvita participates in ProcureCon Pharma 2012
Selvita presents at The 14th Annual BIO CEO & Investor Conference
Selvita presents at the 5th Annual European Life Science CEO Forum for Partnering & Investing
Selvita presents at BIO-Europe Spring 2012
Selvita released the most recent results from its oncology programs at the 2011 AACR-EORTC-NCI
Selvita ranked the no. 1 Rising Star in Deloitte Technology Fast 50 Central Europe
Selvita signs a contract with Evestra for the delivery of a range of DMPK services
Selvita's BioCentrum obtains a Certificate of Good Laboratory Practice (GLP)
